1. Home
  2. U vs RGEN Comparison

U vs RGEN Comparison

Compare U & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Software Inc.

U

Unity Software Inc.

HOLD

Current Price

$19.84

Market Cap

8.6B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$117.54

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
U
RGEN
Founded
2004
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
8.1B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
U
RGEN
Price
$19.84
$117.54
Analyst Decision
Buy
Buy
Analyst Count
22
11
Target Price
$36.99
$173.09
AVG Volume (30 Days)
12.5M
840.9K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
42.86
286.96
EPS
N/A
0.86
Revenue
$1,849,648,000.00
$141,236,000.00
Revenue This Year
$14.94
$14.11
Revenue Next Year
$12.70
$14.71
P/E Ratio
N/A
$136.91
Revenue Growth
2.01
35.10
52 Week Low
$15.33
$102.97
52 Week High
$52.15
$175.77

Technical Indicators

Market Signals
Indicator
U
RGEN
Relative Strength Index (RSI) 39.93 35.89
Support Level $16.78 $113.07
Resistance Level $21.58 $132.51
Average True Range (ATR) 1.14 4.95
MACD 0.73 0.19
Stochastic Oscillator 54.37 24.57

Price Performance

Historical Comparison
U
RGEN

About U Unity Software Inc.

Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. Its products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: